These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 14696098)

  • 21. CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
    Yang XF; Wu CJ; Chen L; Alyea EP; Canning C; Kantoff P; Soiffer RJ; Dranoff G; Ritz J
    Cancer Res; 2002 Oct; 62(19):5517-5522. PubMed ID: 12359762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
    Scanlan MJ; Welt S; Gordon CM; Chen YT; Gure AO; Stockert E; Jungbluth AA; Ritter G; Jäger D; Jäger E; Knuth A; Old LJ
    Cancer Res; 2002 Jul; 62(14):4041-7. PubMed ID: 12124339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer.
    Obara W; Ohsawa R; Kanehira M; Takata R; Tsunoda T; Yoshida K; Takeda K; Katagiri T; Nakamura Y; Fujioka T
    Jpn J Clin Oncol; 2012 Jul; 42(7):591-600. PubMed ID: 22636067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral immune responses to testis antigens in sera from patients with prostate cancer.
    Hoeppner LH; Dubovsky JA; Dunphy EJ; McNeel DG
    Cancer Immun; 2006 Jan; 6():1. PubMed ID: 16401063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis.
    Dubovsky JA; Albertini MR; McNeel DG
    J Immunother; 2007 Oct; 30(7):675-83. PubMed ID: 17893560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.
    Ono T; Kurashige T; Harada N; Noguchi Y; Saika T; Niikawa N; Aoe M; Nakamura S; Higashi T; Hiraki A; Wada H; Kumon H; Old LJ; Nakayama E
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3282-7. PubMed ID: 11248070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma.
    Nishizaka S; Gomi S; Harada K; Oizumi K; Itoh K; Shichijo S
    Cancer Res; 2000 Sep; 60(17):4830-7. PubMed ID: 10987294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
    Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
    Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.
    Chiari R; Foury F; De Plaen E; Baurain JF; Thonnard J; Coulie PG
    Cancer Res; 1999 Nov; 59(22):5785-92. PubMed ID: 10582700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTp11, a novel member of the family of human cancer/testis antigens.
    Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
    Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.
    Fukuyama T; Hanagiri T; Takenoyama M; Ichiki Y; Mizukami M; So T; Sugaya M; So T; Sugio K; Yasumoto K
    Cancer Res; 2006 May; 66(9):4922-8. PubMed ID: 16651449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
    Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
    Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
    Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
    Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response.
    Di Modugno F; Bronzi G; Scanlan MJ; Del Bello D; Cascioli S; Venturo I; Botti C; Nicotra MR; Mottolese M; Natali PG; Santoni A; Jager E; Nisticò P
    Int J Cancer; 2004 May; 109(6):909-18. PubMed ID: 15027125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas.
    Chen PF; Freedman RS; Chernajovsky Y; Platsoucas CD
    Hum Antibodies Hybridomas; 1994; 5(3-4):131-42. PubMed ID: 7756578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y; Okada Y; Terachi T; Yoshida O
    J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library.
    Somers VA; Brandwijk RJ; Joosten B; Moerkerk PT; Arends JW; Menheere P; Pieterse WO; Claessen A; Scheper RJ; Hoogenboom HR; Hufton SE
    J Immunol; 2002 Sep; 169(5):2772-80. PubMed ID: 12193752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
    Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB
    Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.
    Jerome KR; Barnd DL; Bendt KM; Boyer CM; Taylor-Papadimitriou J; McKenzie IF; Bast RC; Finn OJ
    Cancer Res; 1991 Jun; 51(11):2908-16. PubMed ID: 1709586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
    Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
    Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.